Session Information
Date: Monday, October 22, 2018
Title: Systemic Lupus Erythematosus – Clinical Poster II: Biomarkers and Outcomes
Session Type: ACR Poster Session B
Session Time: 9:00AM-11:00AM
Background/Purpose: Evaluation of lupus flares is inconsistent using glossary-based definitions for grading (1). BILAG 2004 rates flares by new/worse organ scores. The SELENA-SLEDAI flare index (SFI) combines treatment change, new/worse features, and a weighted physician’s global assessment (SFI-PGA) visual analogue scale (VAS). A modified SFI (mSFI) improves accuracy by excluding medication criteria while clinicians differentiate mild from moderate flare (2). The Rapid Evaluation of Activity in Lupus (LFA-REALTM) expands the SFI-PGA and other earlier systems (3) for comprehensive VAS-based evaluation of individual symptoms, organs, or global disease. We compared mSFI and BILAG flares during a clinical trial, using SFI-PGA and LFA-REALTM to clarify their differences.
Methods: Disease activity (SLEDAI, BILAG 2004, mSFI, SFI-PGA, and LFA-REALTM) was rated monthly in a clinical trial. Severity of mSFI and BILAG flares was compared to SFI-PGA and LFA-REALTM changes by receiver operating characteristic (ROC) curve analysis.
Results: 50 SLE patients were examined at 430 monthly visit pairs. The mSFI defined 108 flares (73 mild, 34 moderate, 1 severe); BILAG only 77 (63 mild, 8 moderate, 6 severe) (Table 1). The mSFI rated 36 mild BILAG flares as mild and 26 as moderate. These were effectively discriminated by SFI-PGA or LFA-REALTM (p<0.001). There were 34 moderate mSFI flares vs only 8 by BILAG (new/worse B in ≥2 organ domains). Also, mSFI flare was scored in 32 of 353 visit pairs with no BILAG flare (27 with mild flare in <3 BILAG domains). Both SFI-PGA and LFA-REALTM captured flares by mSFI or BILAG (ROC analysis, p<0.0001 for all). Mild vs moderate/severe mSFI flares were distinguished by SFI-PGA or LFA-REALTM. Only LFA-REALTM reflected mild vs moderate/severe flares by BILAG (Table 2).
Table 1. Flares by mSFI and BILAG 2004.
mSFI flares |
||||||
none |
mild |
moderate |
severe |
total |
||
BILAG flares |
none |
321 |
32 |
0 |
0 |
353 |
mild |
1 |
36 |
26 |
0 |
63 |
|
moderate |
0 |
5 |
3 |
0 |
8 |
|
severe |
0 |
0 |
5 |
1 |
6 |
|
total |
322 |
73 |
34 |
1 |
430 |
Table 2. ROC analysis of changes in SFI-PGA and LFA-REALTM in differentiating mild from moderate/severe flares by mSFI and BILAG 2004.
|
|
mSFI |
BILAG |
Δ LFA-REALTM
|
AUC |
0.7714 |
0.7466 |
p value |
<0.0001 |
0.0041 |
|
Δ SFI-PGA |
AUC |
0.8348 |
0.6587 |
|
p value |
<0.0001 |
0.0645 |
Conclusion: BILAG and mSFI flares are captured by changes in SFI-PGA or LFA-REALTM. BILAG flare thresholds are higher (mild flares require increase in 3 organs; moderate flares in a single organ default to mild). SFI compresses these into “mild-moderate”, which hinders clinically significant distinctions. The mSFI clinician’s discrimination of mild vs moderate/severe flare is supported by SFI-PGA or LFA-REALTM changes. LFA-REALTM can also distinguish mild vs moderate/severe BILAG flares, likely due to its expanded multisystem scale.
References: 1. Isenberg D, et al. Arthritis Care Res. 2018;70:98-103, 2. Thanou A, et al. Rheumatology 2014;53:2175-2181, 3. Petri M, et al. J Rheumatol.1992;19:53-9.
To cite this abstract in AMA style:
Thanou A, Askanase A, Arriens C, Aberle T, Kamp S, Chakravarty E, James JA, Merrill JT. Systemic Lupus Flares Based on BILAG and Sledai Rules Are Inconsistent, but May be Better Understood Using Visual Analogue Scales [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/systemic-lupus-flares-based-on-bilag-and-sledai-rules-are-inconsistent-but-may-be-better-understood-using-visual-analogue-scales/. Accessed .« Back to 2018 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/systemic-lupus-flares-based-on-bilag-and-sledai-rules-are-inconsistent-but-may-be-better-understood-using-visual-analogue-scales/